94 related articles for article (PubMed ID: 2635243)
1. A study on immunological effects of L-canavanine.
Morimoto I
Kobe J Med Sci; 1989 Dec; 35(5-6):287-98. PubMed ID: 2635243
[TBL] [Abstract][Full Text] [Related]
2. L-canavanine acts on suppressor-inducer T cells to regulate antibody synthesis: lymphocytes of systemic lupus erythematosus patients are specifically unresponsive to L-canavanine.
Morimoto I; Shiozawa S; Tanaka Y; Fujita T
Clin Immunol Immunopathol; 1990 Apr; 55(1):97-108. PubMed ID: 2137742
[TBL] [Abstract][Full Text] [Related]
3. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
Weill BJ; Renoux ML
Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
[TBL] [Abstract][Full Text] [Related]
4. Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus.
González-Amaro R; Portales-Pérez D; Baranda L; Abud-Mendoza C; Llorente L; Richaud-Patin Y; Alcocer-Varela J; Alarcón-Segovia D
J Autoimmun; 1998 Oct; 11(5):395-402. PubMed ID: 9802922
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus.
Saiki O; Saeki Y; Kishimoto S
J Clin Invest; 1985 Nov; 76(5):1865-70. PubMed ID: 3932473
[TBL] [Abstract][Full Text] [Related]
6. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
[TBL] [Abstract][Full Text] [Related]
7. Effects of L-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa.
Alcocer-Varela J; Iglesias A; Llorente L; Alarcón-Segovia D
Arthritis Rheum; 1985 Jan; 28(1):52-7. PubMed ID: 3155617
[TBL] [Abstract][Full Text] [Related]
8. Nuclear DNA degradation in lymphocytes of patients with systemic lupus erythematosus.
Compton LJ; Steinberg AD; Sano H
J Immunol; 1984 Jul; 133(1):213-6. PubMed ID: 6725954
[TBL] [Abstract][Full Text] [Related]
9. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
10. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases.
Nakamura T; Miyasaka N; Pope RM; Talal N; Russell IJ
Clin Exp Immunol; 1983 Apr; 52(1):67-74. PubMed ID: 6190598
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
Tsokos GC; Magrath IT; Balow JE
J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
[TBL] [Abstract][Full Text] [Related]
13. Role of non-protein amino acid L-canavanine in autoimmunity.
Akaogi J; Barker T; Kuroda Y; Nacionales DC; Yamasaki Y; Stevens BR; Reeves WH; Satoh M
Autoimmun Rev; 2006 Jul; 5(6):429-35. PubMed ID: 16890899
[TBL] [Abstract][Full Text] [Related]
14. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with anti-class II antibody.
Tanaka Y; Shirakawa F; Ota T; Suzuki H; Eto S; Yamashita U
J Immunol; 1988 Feb; 140(3):761-7. PubMed ID: 3276779
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
Clough JD; Krakauer RA; Frank SA; Calabrese LH
Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
18. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
19. [Suppressor hyperactivity in relation to allogeneic lymphocyte proliferation as a manifestation of T- T-cell interaction defects in systemic lupus erythematosus].
Stenina MA; Potapova AA; Biriukov AV; Skripnik AIu; Cheredeev AH
Biull Eksp Biol Med; 1986 Aug; 102(8):215-7. PubMed ID: 2874848
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
